Vnitr Lek 2022, 68(8):E08-E11 | DOI: 10.36290/vnl.2022.115

Liddle syndrome

Štěpán Mareš, Jan Filipovský
II. interní klinika LF UK a FN Plzeň

Liddle syndrome is an inherited form of arterial hypertension with autosomal dominant pattern of inheritance. It is caused by activating mutation of genes coding of the epithelial sodium channel in distal nephron. Mutation leads to excessive reabsorbtion of sodium ions and volume expansion resulting in arterial hypertension. Antoher typical laboratory findings are hypokalaemia, low levels of serum aldosteron and metabolic alkalosis. Phenotypic variability makes it difficult to identify patients with Liddle syndrome, often resulting in misdiagnosis and severe complications at early age. Genetic studies should be done to confirm the diagnosis. Therapy of Liddle syndrome is based on administration of epithelial sodium channel blocker amilorid.

Keywords: aldosterone, amilorid, arterial hypertension, epithelial sodium channel, hypokalaemia, Liddle syndrome, NEDD4.

Accepted: December 13, 2022; Published: December 6, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Mareš Š, Filipovský J. Liddle syndrome. Vnitr Lek. 2022;68(8):E08-11. doi: 10.36290/vnl.2022.115.
Download citation

References

  1. Wang LP, Yang KQ, Jiang XJ, Wu HY, Zhang HM, Zou YB et al. Prevalence of Liddle Syndrome Among Young Hypertension Patients of Undetermined Cause in a Chinese Population. J Clin Hypertens (Greenwich). 2015 Nov;17(11):902-7. Go to original source... Go to PubMed...
  2. Liu K, Qin F, Sun X, Zhang Y, Wang J, Wu Y et al. Analysis of the genes involved in Mendelian forms of low‑renin hypertension in Chinese early‑onset hypertensive patients. J Hypertens. 2018 Mar;36(3):502-9. Go to original source... Go to PubMed...
  3. Canessa CM, Schild L, Buell G, Thorens B, Gautschi I, Horisberger JD et al. Amiloride‑sensitive epithelial Na+ channel is made of three homologous subunits. Nature. 1994 Feb 3;367(6462):463-7. Go to original source... Go to PubMed...
  4. Hanukoglu I, Hanukoglu A. Epithelial sodium channel (ENaC) family: Phylogeny, structure‑function, tissue distribution, and associated inherited diseases. Gene. 2016 Apr 1;579(2):95-132. Go to original source... Go to PubMed...
  5. Ceccato F, Mantero F. Monogenic Forms of Hypertension. Endocrinol Metab Clin North Am. 2019 Dec;48(4):795-810. Go to original source... Go to PubMed...
  6. Palmer BF, Alpern RJ. Liddle's syndrome. Am J Med. 1998 Mar;104(3):301-9. Go to original source... Go to PubMed...
  7. Tetti M, Monticone S, Burrello J, Matarazzo P, Veglio F, Pasini B et al. Liddle Syndrome: Review of the Literature and Description of a New Case. Int J Mol Sci. 2018 Mar 11;19(3). Go to original source... Go to PubMed...
  8. Fan P, Pan XC, Zhang D, Yang KQ, Zhang Y, Tian T et al. Pediatric Liddle Syndrome Caused by a Novel SCNN1G Variant in a Chinese Family and Characterized by Early‑onset Hypertension. Am J Hypertens. 2020 Mar 12. Go to original source... Go to PubMed...
  9. Gong L, Chen J, Shao L, Song W, Hui R, Wang Y. Phenotype‑genotype analysis in two Chinese families with Liddle syndrome. Mol Biol Rep. 2014 Mar;41(3):1569-75. Go to original source... Go to PubMed...
  10. Mareš Š, Filipovský J, Vlková K, Pešta M, Černá V, Hrabák J et al. A novel nonsense mutation in the β‑subunit of the epithelial sodium channel causing Liddle syndrome. Blood Press. 2021 Oct;30(5):291-9. Go to original source... Go to PubMed...
  11. Enslow BT, Stockand JD, Berman JM. Liddle's syndrome mechanisms, diagnosis and management. Integr Blood Press Control. 2019;12:13-22. Go to original source... Go to PubMed...
  12. Cui Y, Tong A, Jiang J, Wang F, Li C. Liddle syndrome: clinical and genetic profiles. J Clin Hypertens (Greenwich). 2017 May;19(5):524-9. Go to original source... Go to PubMed...
  13. Yang KQ, Xiao Y, Tian T, Gao LG, Zhou XL. Molecular genetics of Liddle's syndrome. Clin Chim Acta. 2014 Sep 25;436:202-6. Go to original source... Go to PubMed...
  14. Schild L, Lu Y, Gautschi I, Schneeberger E, Lifton RP, Rossier Bc. Identification of a PY motif in the epithelial Na channel subunits as a target sequence for mutations causing channel activation found in Liddle syndrome. Embo j. 1996 May 15;15(10):2381-7. Go to original source... Go to PubMed...
  15. Salih M, Gautschi I, van Bemmelen MX, Di Benedetto M, Brooks AS, Lugtenberg D, et al. A Missense Mutation in the Extracellular Domain of alphaENaC Causes Liddle Syndrome. J Am Soc Nephrol. 2017 Nov;28(11):3291-9. Go to original source... Go to PubMed...
  16. Botero‑Velez M, Curtis JJ, Warnock DG. Brief report: Liddle's syndrome revisited--a disorder of sodium reabsorption in the distal tubule. N Engl J Med. 1994 Jan 20;330(3):178-81. Go to original source... Go to PubMed...
  17. Al Khaja KA, Sequeira RP, Alkhaja AK, Damanhori AH. Drug treatment of hypertension in pregnancy: a critical review of adult guideline recommendations. J Hypertens. 2014 Mar;32(3):454-63. Go to original source... Go to PubMed...
  18. Podymow T, August P. Hypertension in pregnancy. Adv Chronic Kidney, DiS. 2007 Apr;14(2):178-90. Go to original source... Go to PubMed...
  19. Caretto A, Primerano L, Novara F, Zuffardi O, Genovese S, Rondinell, M.A. Therapeutic Challenge: Liddle's Syndrome Managed with Amiloride during Pregnancy. Case Rep Obstet Gynecol. 2014;2014:156250. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.